Director, Molecular Pathology

Pathology

Tina Edmonston, MD works in the field of Pathology. Tina Edmonston is a published physician. She published 21 publications, including: 'Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary.' She is registered with Medicare.

Publications

---

• Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary.
• Accurate classification of metastatic brain tumors using a novel microRNA-based test.
• A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.
• Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.
• Graft-versus-Host Disease-Like Pattern in Mycophenolate Mofetil Related Colon Mucosal Injury: Role of FISH in Establishing the Diagnosis.
• The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression.
• DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.
• Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.
• Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive ...
• Invasive papillary adenocarcinoma of the colon.
• Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer.
• Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing.
• The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international co...
• The role of mismatch repair in small-cell lung cancer cells.
• MSI-testing in hereditary non-polyposis colorectal carcinoma (HNPCC).
• Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy.
• Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry.
• Colorectal carcinomas with high microsatellite instability: defining a distinct immunologic and molecular entity with respect to prognostic markers.
• Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum.
• Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer.

Schools

---

• LudwigMaximiliansUniversitaet Munchen Fachbereich Medizin

• Thomas Jefferson University Hospital

• Hospital Of The University Of Pennsylvania

Doctors Specialties

---

• Pathology

Accepted Insurances

---

Education

---

• Thomas Jefferson University
• Ludwig Maximilian University of Munich Faculty of Medicine

Hospital

---

• Cooper University Health Care

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1679581284
Last Name Of The Provider	EDMONSTON
First Name Of The Provider	TINA
View All

Similar Doctors

---

	Dr. Hoon Kim, MD This Doctor is OpenDoctor Recommended.
	Dr. Roland Schwarting, MD This Doctor is OpenDoctor Recommended.
	Dr. Miles M. McFarland, MD This Doctor is OpenDoctor Recommended.
	Dr. William D. Kocher, MD This Doctor is OpenDoctor Recommended.
	Dr. William J. Klump, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas Holdbrook, MD This Doctor is OpenDoctor Recommended.
	Dr. Helen M. Haupt, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jeanette M. Camacho, MD This Doctor is OpenDoctor Recommended.
	Dr. Charlene M. Bierl, MD This Doctor is OpenDoctor Recommended.
	Dr. Eric M. Behling, MD This Doctor is OpenDoctor Recommended.
	Dr. Carolyn Grotkowski, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog